Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point
On Air
Feedback
Low Graphics
Help

Sunday, February 21, 1999 Published at 04:12 GMT


Health

Cervical cancer vaccine on the way

While the UK screens, most deaths occur in the developing world

A genetically-engineered vaccine against cervical cancer is on its way, marking another major step in the battle against the disease, the World Health Organisation has said.

It would be the second vaccine against a major human cancer, following a hepatitis B vaccine that prevents primary liver cancer.

If successful, it could pave the way to defeat for the second most prevalent cancer among women. Breast cancer is the first.

WHO scientists were meeting this week in Geneva to take stock of developments. On Friday they said there are several candidates for such a vaccine.

Tackling a global problem

There are 500,000 new cases of cervical cancer each year, and nearly 300,000 deaths annually, according to the WHO.

Eighty 80 per cent of these occur in developing countries.

Scientists believe that essentially all cervical cancer is caused by infection with a few types of human papillomavirus (HPV).

Scientists looking to develop a vaccine have approached the problem from different angles, but have mainly focussed on genetically-engineered VLPs (virus-like particles).

These are not infectious and cannot cause cancer because they contain no DNA.

Some of the research groups are looking at creating a vaccine that prevents the cancer developing at all.

Others are developing vaccines that would prevent recurrence of cancer or tackle it once it has developed.

Hurdles before the finishing post

The scientists said they all faced "huge obstacles".

Part of the reason for this is that their experimentation is limited, because fully infectious HPVs are harmful.

The meeting agreed that a preventive vaccine should have priority.

Ideally this could be targeted at a young population that is not yet sexually active, although older people may also benefit from such a vaccine, they said.

The WHO said the vaccine trials must include representative groups "to ensure global relevance".



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

05 Feb 99 | Health
Restricting cervical screening could save millions

29 Jan 99 | Health
Cancer vaccine prevents relapse

04 Nov 98 | Health
Cancer immunity - at a price

03 Jul 98 | Health
Cancer on the retreat

01 Jun 98 | Latest News
A vaccine for blood cancer?





Internet Links


NHS Cervical Screening Programme

World Health Organisation

Institute of Cancer Research


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99